Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Lung Cancer

Free Subscription Articles published in Cancer Lett Retrieve available abstracts of 189 articles: HTML format

Single Articles

March 2021
1. LIN CY, Huang KY, Lin YC, Yang SC, et al
   Vorinostat combined with brigatinib overcomes acquired resistance in EGFR-C797S-mutated lung cancer.
   Cancer Lett. 2021;508:76-91.
   PubMed     Abstract available
   
   
   
2. LEE S, Hong JH, Kim JS, Yoon JS, et al
   Cancer-associated fibroblasts activated by miR-196a promote the migration and invasion of lung cancer cells.
   Cancer Lett. 2021;508:92-103.
   PubMed     Abstract available
   
   
   January 2021
3. WANG J, Sun T, Meng Z, Wang L, et al
   XPO1 inhibition synergizes with PARP1 inhibition in small cell lung cancer by targeting nuclear transport of FOXO3a.
   Cancer Lett. 2021 Jan 22. pii: S0304-3835(21)00024.
   PubMed     Abstract available
   
   
   
4. TANG S, Li S, Liu T, He Y, et al
   MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer.
   Cancer Lett. 2021;502:71-83.
   PubMed     Abstract available
   
   
   
5. ZHOU S, Xie J, Huang Z, Deng L, et al
   Anti-PD-(L)1 immunotherapy for brain metastases in non-small cell lung cancer: Mechanisms, advances, and challenges.
   Cancer Lett. 2021 Jan 12. pii: S0304-3835(21)00008.
   PubMed     Abstract available
   
   
   December 2020
6. LO SARDO F, Pulito C, Sacconi A, Korita E, et al
   YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancer.
   Cancer Lett. 2020 Dec 6. pii: S0304-3835(20)30636.
   PubMed     Abstract available
   
   
   
7. YAO S, Shi F, Mu N, Li X, et al
   Angio-associated migratory cell protein (AAMP) interacts with cell division cycle 42 (CDC42) and enhances migration and invasion in human non-small cell lung cancer cells.
   Cancer Lett. 2020 Dec 3. pii: S0304-3835(20)30648.
   PubMed     Abstract available
   
   
   
8. ZHOU L, Xu Q, Huang L, Jin J, et al
   Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer.
   Cancer Lett. 2020 Dec 2. pii: S0304-3835(20)30647.
   PubMed     Abstract available
   
   
   
9. CHEN D, Wu X, Chen Y, Chen C, et al
   Comment on 'Clinical significance and inflammatory landscapes of a novel recurrence associated immune signature in early-stage lung adenocarcinoma'.
   Cancer Lett. 2020;494:17.
   PubMed    
   
   
   
10. SUN N, Zhang C, He J
    Response to comment on 'Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma'.
    Cancer Lett. 2020;494:5-6.
    PubMed    
    
    
    November 2020
11. ZHENG Y, Wang Z, Wei S, Liu Z, et al
    Epigenetic silencing of chemokine CCL2 represses macrophage infiltration to potentiate tumor development in small cell lung cancer.
    Cancer Lett. 2020 Nov 28. pii: S0304-3835(20)30632.
    PubMed     Abstract available
    
    
    
12. XIE J, Yang P, Lin HP, Li Y, et al
    Integrin alpha4 up-regulation activates the hedgehog pathway to promote arsenic and benzo[alpha]pyrene co-exposure-induced cancer stem cell-like property and tumorigenesis.
    Cancer Lett. 2020;493:143-155.
    PubMed     Abstract available
    
    
    
13. YAO C, Su L, Zhang F, Zhu X, et al
    Thevebioside, the active ingredient of traditional Chinese medicine, promotes ubiquitin-mediated SRC-3 degradation to induce NSCLC cells apoptosis.
    Cancer Lett. 2020;493:167-177.
    PubMed     Abstract available
    
    
    
14. YUAN J, Xing H, Li Y, Song Y, et al
    EPB41 suppresses the Wnt/beta-catenin signaling in non-small cell lung cancer by sponging ALDOC.
    Cancer Lett. 2020 Nov 24. pii: S0304-3835(20)30622.
    PubMed     Abstract available
    
    
    
15. SHIH CT, Shiau CW, Chen YL, Chen LJ, et al
    TD-92, a novel erlotinib derivative, depletes tumor-associated macrophages in non-small cell lung cancer via down-regulation of CSF-1R and enhances the anti-tumor effects of anti-PD-1.
    Cancer Lett. 2020 Nov 21. pii: S0304-3835(20)30577.
    PubMed     Abstract available
    
    
    
16. LI J, Gao A, Zhang F, Wang S, et al
    ILT3 promotes tumor cell motility and angiogenesis in non-small cell lung cancer.
    Cancer Lett. 2020 Nov 2. pii: S0304-3835(20)30582.
    PubMed     Abstract available
    
    
    October 2020
17. PHAM K, Huynh D, Le L, Delitto D, et al
    E-cigarette promotes breast carcinoma progression and lung metastasis: Macrophage-tumor cells crosstalk and the role of CCL5 and VCAM-1.
    Cancer Lett. 2020;491:132-145.
    PubMed     Abstract available
    
    
    
18. MULET M, Zamora C, Porcel JM, Nieto JC, et al
    Platelet factor 4 regulates T cell effector functions in malignant pleural effusions.
    Cancer Lett. 2020;491:78-86.
    PubMed     Abstract available
    
    
    
19. HAQUE A, Rahman MA, Fuchs JR, Chen Z, et al
    Corrigendum to "FLLL12 induces apoptosis in lung cancer cells through a p53/p73-independent but death receptor 5-dependent pathway" [Canc. Lett. 363 (2015) 166-175].
    Cancer Lett. 2020 Oct 20. pii: S0304-3835(20)30395.
    PubMed    
    
    
    
20. MIYASHITA N, Horie M, Mikami Y, Urushiyama H, et al
    ASCL1 promotes tumor progression through cell-autonomous signaling and immune modulation in a subset of lung adenocarcinoma.
    Cancer Lett. 2020;489:121-132.
    PubMed     Abstract available
    
    
    September 2020
21. PARK S, Kim TM, Cho SY, Kim S, et al
    Combined blockade of polo-like kinase and pan-RAF is effective against NRAS-mutant non-small cell lung cancer cells.
    Cancer Lett. 2020;495:135-144.
    PubMed     Abstract available
    
    
    
22. QUAN C, Chen Y, Wang X, Yang D, et al
    Loss of histone lysine methyltransferase EZH2 confers resistance to tyrosine kinase inhibitors in non-small cell lung cancer.
    Cancer Lett. 2020 Sep 10. pii: S0304-3835(20)30465.
    PubMed     Abstract available
    
    
    
23. MAHMUD F, Deng S, Chen H, Miller DD, et al
    Orally available tubulin inhibitor VERU-111 enhances antitumor efficacy in paclitaxel-resistant lung cancer.
    Cancer Lett. 2020 Sep 10. pii: S0304-3835(20)30466.
    PubMed     Abstract available
    
    
    
24. ZENG Y, Jie X, Wu B, Wu G, et al
    IQGAP3 interacts with Rad17 to recruit the Mre11-Rad50-Nbs1 complex and contributes to radioresistance in lung cancer.
    Cancer Lett. 2020 Sep 4. pii: S0304-3835(20)30456.
    PubMed     Abstract available
    
    
    August 2020
25. CHEN C, Liu WR, Zhang B, Zhang LM, et al
    LncRNA H19 downregulation confers erlotinib resistance through upregulation of PKM2 and phosphorylation of AKT in EGFR-mutant lung cancers.
    Cancer Lett. 2020;486:58-70.
    PubMed     Abstract available
    
    
    
26. WANG C, Tan S, Li J, Liu WR, et al
    CircRNAs in lung cancer - Biogenesis, function and clinical implication.
    Cancer Lett. 2020 Aug 26. pii: S0304-3835(20)30427.
    PubMed     Abstract available
    
    
    
27. SHOU J, You L, Yao J, Xie J, et al
    Corrigendum to "Cyclosporine A sensitizes human non-small cell lung cancer cells to gefitinib through inhibition of STAT3" [Canc Lett 379 (2016) 124-133].
    Cancer Lett. 2020;493:13-15.
    PubMed    
    
    
    
28. TIAN D, Tang J, Geng X, Li Q, et al
    Targeting UHRF1-dependent DNA repair selectively sensitizes KRAS mutant lung cancer to chemotherapy.
    Cancer Lett. 2020 Aug 16. pii: S0304-3835(20)30421.
    PubMed     Abstract available
    
    
    
29. CASAL-MOURINO A, Ruano-Ravina A, Torres-Duran M, Parente-Lamelas I, et al
    Corrigendum to "Lung cancer survival in never-smokers and exposure to residential radon: Results of the LCRINS study" [Canc. Lett. 487 (2020) 21-26].
    Cancer Lett. 2020;493:10.
    PubMed    
    
    
    
30. TEOH ST, Ogrodzinski MP, Lunt SY
    UDP-glucose 6-dehydrogenase knockout impairs migration and decreases in vivo metastatic ability of breast cancer cells.
    Cancer Lett. 2020 Aug 5. pii: S0304-3835(20)30388.
    PubMed     Abstract available
    
    
    
31. WANG D, Cong J, Fu B, Zheng X, et al
    Immunogenic chemotherapy effectively inhibits KRAS-Driven lung cancer.
    Cancer Lett. 2020 Aug 3. pii: S0304-3835(20)30399.
    PubMed     Abstract available
    
    
    
32. GALLAND S, Martin P, Fregni G, Letovanec I, et al
    Attenuation of the pro-inflammatory signature of lung cancer-derived mesenchymal stromal cells by statins.
    Cancer Lett. 2020;484:50-64.
    PubMed     Abstract available
    
    
    July 2020
33. ZHOU W, Liu Y, Gao Y, Cheng Y, et al
    MICAL2 is a novel nucleocytoplasmic shuttling protein promoting cancer invasion and growth of lung adenocarcinoma.
    Cancer Lett. 2020;483:75-86.
    PubMed     Abstract available
    
    
    
34. JIN R, Wang X, Zang R, Liu C, et al
    Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR/Src/PAK1 pathway in lung adenocarcinoma.
    Cancer Lett. 2020;483:46-58.
    PubMed     Abstract available
    
    
    
35. XU L, Hu H, Zheng LS, Wang MY, et al
    ETV4 is a theranostic target in clear cell renal cell carcinoma that promotes metastasis by activating the pro-metastatic gene FOSL1 in a PI3K-AKT dependent manner.
    Cancer Lett. 2020;482:74-89.
    PubMed     Abstract available
    
    
    
36. OGAWA K, Lin Q, Li L, Bai X, et al
    Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis.
    Cancer Lett. 2020;481:63-75.
    PubMed     Abstract available
    
    
    June 2020
37. YIN H, Wang X, Zhang X, Zeng Y, et al
    UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation.
    Cancer Lett. 2020 Jun 23. pii: S0304-3835(20)30331.
    PubMed     Abstract available
    
    
    
38. HUANG XH, Yan X, Zhang QH, Hong P, et al
    Direct targeting of HSP90 with daurisoline destabilizes beta-catenin to suppress lung cancer tumorigenesis.
    Cancer Lett. 2020 Jun 13. pii: S0304-3835(20)30286.
    PubMed     Abstract available
    
    
    
39. ZHANG C, Zhang Z, Zhang G, Zhang Z, et al
    Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma.
    Cancer Lett. 2020;479:31-41.
    PubMed     Abstract available
    
    
    
40. HUANG F, Ma G, Zhou X, Zhu X, et al
    Depletion of LAMP3 enhances PKA-mediated VASP phosphorylation to suppress invasion and metastasis in esophageal squamous cell carcinoma.
    Cancer Lett. 2020;479:100-111.
    PubMed     Abstract available
    
    
    May 2020
41. MOURINO AC, Ruano-Ravina A, Torres-Duran M, Parente-Lamelas I, et al
    Lung cancer survival in never-smokers and exposure to residential radon: Results of the LCRINS study.
    Cancer Lett. 2020 May 23. pii: S0304-3835(20)30284.
    PubMed     Abstract available
    
    
    
42. ZHAO Z, Zhang N, Li A, Zhou B, et al
    Insulin-like growth factor-1 receptor induces immunosuppression in lung cancer by upregulating B7-H4 expression through the MEK/ERK signaling pathway.
    Cancer Lett. 2020 May 14. pii: S0304-3835(20)30199.
    PubMed     Abstract available
    
    
    
43. YANG YF, Wang YY, Hsiao M, Lo S, et al
    IMPAD1 functions as mitochondrial electron transport inhibitor that prevents ROS production and promotes lung cancer metastasis through the AMPK-Notch1-HEY1 pathway.
    Cancer Lett. 2020 May 14. pii: S0304-3835(20)30227.
    PubMed     Abstract available
    
    
    April 2020
44. ACHYUT BR, Zhang H, Angara K, Mivechi NF, et al
    Oncoprotein GT198 vaccination delays tumor growth in MMTV-PyMT mice.
    Cancer Lett. 2020;476:57-66.
    PubMed     Abstract available
    
    
    
45. CHEN J, Liu A, Lin Z, Wang B, et al
    Downregulation of the Circadian Rhythm Regulator HLF Promotes Multiple-Organ Distant Metastases in Non-Small Cell Lung Cancer through PPAR/NF-kappaB Signaling.
    Cancer Lett. 2020 Apr 11. pii: S0304-3835(20)30184.
    PubMed     Abstract available
    
    
    
46. WANG J, Li X, Chen H
    Organoid models in lung regeneration and cancer.
    Cancer Lett. 2020;475:129-135.
    PubMed     Abstract available
    
    
    
47. KIM DH, Park S, Kim H, Choi YJ, et al
    Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4.
    Cancer Lett. 2020;475:2-13.
    PubMed     Abstract available
    
    
    
48. WANG J, Wu X, Dai W, Li J, et al
    The CCDC43-ADRM1 axis regulated by YY1, promotes proliferation and metastasis of gastric cancer.
    Cancer Lett. 2020 Apr 8. pii: S0304-3835(20)30159.
    PubMed     Abstract available
    
    
    
49. KUO CL, Chou HY, Chiu YC, Cheng AN, et al
    Mitochondrial oxidative stress by Lon-PYCR1 maintains an immunosuppressive tumor microenvironment that promotes cancer progression and metastasis.
    Cancer Lett. 2020;474:138-150.
    PubMed     Abstract available
    
    
    
50. ALMACELLAS-RABAIGET O, Monaco P, Huertas-Martinez J, Garcia-Monclus S, et al
    LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity.
    Cancer Lett. 2020;474:1-14.
    PubMed     Abstract available
    
    
    March 2020
51. LI Y, Liang R, Sun M, Li Z, et al
    AMPK-Dependent Phosphorylation of HDAC8 Triggers PGM1 Expression to Promote Lung Cancer Cell Survival under Glucose Starvation.
    Cancer Lett. 2020 Mar 11. pii: S0304-3835(20)30126.
    PubMed     Abstract available
    
    
    
52. VANBERVLIET-DEFRANCE B, Delaunay T, Daunizeau T, Kepenekian V, et al
    Cisplatin unleashes Toll-like receptor 3-mediated apoptosis through the downregulation of c-FLIP in malignant mesothelioma.
    Cancer Lett. 2020;472:29-39.
    PubMed     Abstract available
    
    
    February 2020
53. ZHENG J, Zhang Y, Cai S, Dong L, et al
    MicroRNA-4651 targets bromodomain-containing protein 4 to inhibit non-small cell lung cancer cell progression.
    Cancer Lett. 2020;476:129-139.
    PubMed     Abstract available
    
    
    January 2020
54. XIAO R, Ding C, Zhu H, Liu X, et al
    Suppression of asparagine synthetase enhances the antitumor potency of ART and artemalogue SOMCL-14-221 in non-small cell lung cancer.
    Cancer Lett. 2020 Jan 31. pii: S0304-3835(20)30049.
    PubMed     Abstract available
    
    
    
55. TAN HY, Wang N, Chan YT, Zhang C, et al
    ID1 overexpression increases gefitinib sensitivity in non-small cell lung cancer by activating RIP3/MLKL-dependent necroptosis.
    Cancer Lett. 2020 Jan 28. pii: S0304-3835(20)30039.
    PubMed     Abstract available
    
    
    
56. SEIDL C, Panzitt K, Bertsch A, Brcic L, et al
    MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2.
    Cancer Lett. 2020;469:266-276.
    PubMed     Abstract available
    
    
    
57. ZHANG L, Zhang X, Liu Y, Zhang T, et al
    PD-L1(+) aneuploid circulating tumor endothelial cells (CTECs) exhibit resistance to the checkpoint blockade immunotherapy in advanced NSCLC patients.
    Cancer Lett. 2020;469:355-366.
    PubMed     Abstract available
    
    
    
58. ZHOU Y, Zhou Y, Wang K, Li T, et al
    Flumethasone enhances the efficacy of chemotherapeutic drugs in lung cancer by inhibiting Nrf2 signaling pathway.
    Cancer Lett. 2020 Jan 16. pii: S0304-3835(20)30018.
    PubMed     Abstract available
    
    
    
59. YU JJ, Zhou DD, Cui B, Zhang C, et al
    Disruption of the EGFR-SQSTM1 Interaction by a Stapled Peptide Suppresses Lung Cancer via Activating Autophagy and Inhibiting EGFR Signaling.
    Cancer Lett. 2020 Jan 10. pii: S0304-3835(20)30012.
    PubMed     Abstract available
    
    
    
60. ZHOU Z, Zhou Q, Wu X, Xu S, et al
    VCAM-1 secreted from cancer-associated fibroblasts enhances the growth and invasion of lung cancer cells through AKT and MAPK signaling.
    Cancer Lett. 2020;473:62-73.
    PubMed     Abstract available
    
    
    December 2019
61. LI Y, Chen F, Shen W, Li B, et al
    WDR74 induces nuclear beta-catenin accumulation and activates Wnt-responsive genes to promote lung cancer growth and metastasis.
    Cancer Lett. 2019 Dec 12. pii: S0304-3835(19)30617.
    PubMed     Abstract available
    
    
    
62. LI X, Tong LJ, Ding J, Meng LH, et al
    Corrigendum to "Systematic combination screening reveals synergism between rapamycin and sutent against human lung cancer" [Cancer Letter 342(2014) 159-166].
    Cancer Lett. 2019 Dec 6. pii: S0304-3835(19)30592.
    PubMed    
    
    
    October 2019
63. ZHANG L, Zhu B, Zeng Y, Shen H, et al
    Clinical Lipidomics In Understanding Of Lung Cancer: Opportunity And Challenge.
    Cancer Lett. 2019 Oct 23. pii: S0304-3835(19)30451.
    PubMed     Abstract available
    
    
    
64. LIU C, Zheng S, Jin R, Wang X, et al
    The superior efficacy of anti-PD-1/PD-L1 immunotherapy in KRAS-mutant non-small cell lung cancer that correlates with an inflammatory phenotype and increased immunogenicity.
    Cancer Lett. 2019 Oct 20. pii: S0304-3835(19)30524.
    PubMed     Abstract available
    
    
    
65. YANG D, Liu Y, Bai C, Wang X, et al
    Epidemiology of lung cancer and lung cancer screening program in China and the United States.
    Cancer Lett. 2019 Oct 7. pii: S0304-3835(19)30500.
    PubMed     Abstract available
    
    
    September 2019
66. HAMMAD A, Namani A, Elshaer M, Wang XJ, et al
    "NRF2 Addiction" in Lung Cancer Cells and Its Impact on Cancer Therapy.
    Cancer Lett. 2019 Sep 28. pii: S0304-3835(19)30488.
    PubMed     Abstract available
    
    
    
67. REDA M, Ngamcherdtrakul W, Gu S, Bejan DS, et al
    PLK1 and EGFR targeted nanoparticle as a radiation sensitizer for non-small cell lung cancer.
    Cancer Lett. 2019 Sep 26. pii: S0304-3835(19)30486.
    PubMed     Abstract available
    
    
    
68. ZOU H, Chen H, Zhou Z, Wan Y, et al
    ATXN3 promotes breast cancer metastasis by deubiquitinating KLF4.
    Cancer Lett. 2019 Sep 26. pii: S0304-3835(19)30484.
    PubMed     Abstract available
    
    
    
69. KIM YJ, Baek DS, Lee S, Park D, et al
    Dual-targeting of EGFR and Neuropilin-1 Attenuates Resistance to EGFR-targeted Antibody Therapy in KRAS-mutant Non-Small Cell Lung Cancer.
    Cancer Lett. 2019 Sep 12. pii: S0304-3835(19)30469.
    PubMed     Abstract available
    
    
    August 2019
70. KUANG Y, Wang Q
    Iron and Lung Cancer.
    Cancer Lett. 2019 Aug 19. pii: S0304-3835(19)30438.
    PubMed     Abstract available
    
    
    
71. FOURNEL L, Wu Z, Stadler N, Damotte D, et al
    Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer.
    Cancer Lett. 2019 Aug 9. pii: S0304-3835(19)30428.
    PubMed     Abstract available
    
    
    June 2019
72. ZHANG YC, Zhou Q, Wu YL
    Clinical management of third-generation EGFR inhibitor-resistant patients with advanced non-small cell lung cancer: current status and future perspectives.
    Cancer Lett. 2019 Jun 12. pii: S0304-3835(19)30346.
    PubMed     Abstract available
    
    
    May 2019
73. FLAHERTY RL, Intabli H, Falcinelli M, Bucca G, et al
    Stress hormone-mediated acceleration of breast cancer metastasis is halted by inhibition of nitric oxide synthase.
    Cancer Lett. 2019 May 24. pii: S0304-3835(19)30322.
    PubMed     Abstract available
    
    
    
74. LI Y, Acharya G, Elahy M, Xin H, et al
    The Anthelmintic Flubendazole Blocks Human Melanoma Growth and Metastasis and Suppresses Programmed Cell Death Protein-1 and Myeloid-Derived Suppressor Cell Accumulation.
    Cancer Lett. 2019 May 22. pii: S0304-3835(19)30321.
    PubMed     Abstract available
    
    
    
75. LIU X, Pu W, He H, Fan X, et al
    Novel ROR1 Inhibitor ARI-1 Suppresses the Development of Non-Small Cell Lung Cancer.
    Cancer Lett. 2019 May 21. pii: S0304-3835(19)30311.
    PubMed     Abstract available
    
    
    April 2019
76. SINGHAL J, Chikara S, Horne D, Salgia R, et al
    RLIP inhibition suppresses breast-to-lung metastasis.
    Cancer Lett. 2019;447:24-32.
    PubMed     Abstract available
    
    
    March 2019
77. LI L, Wang Y, Jiao L, Lin C, et al
    Protective autophagy decreases osimertinib cytotoxicity through regulation of stem cell-like properties in lung cancer.
    Cancer Lett. 2019 Mar 22. pii: S0304-3835(19)30183.
    PubMed     Abstract available
    
    
    
78. EXPOSITO F, Villalba M, Redrado M, de Aberasturi AL, et al
    Targeting of TMPRSS4 sensitizes lung cancer cells to chemotherapy by impairing the proliferation machinery.
    Cancer Lett. 2019 Mar 21. pii: S0304-3835(19)30169.
    PubMed     Abstract available
    
    
    
79. SHIMOMURA I, Yokoi A, Kohama I, Kumazaki M, et al
    Drug library screen reveals benzimidazole derivatives as selective cytotoxic agents for KRAS-mutant lung cancer.
    Cancer Lett. 2019;451:11-22.
    PubMed     Abstract available
    
    
    
80. CASAL-MOURINO A, Valdes L, Barros-Dios JM, Ruano-Ravina A, et al
    Lung cancer survival among never smokers.
    Cancer Lett. 2019 Mar 6. pii: S0304-3835(19)30133.
    PubMed     Abstract available
    
    
    
81. CAO L, Wang F, Li S, Wang X, et al
    PIM1 kinase promotes cell proliferation, metastasis and tumor growth of lung adenocarcinoma by potentiating the c-MET signaling pathway.
    Cancer Lett. 2019;444:116-126.
    PubMed     Abstract available
    
    
    
82. LI JY, Xiao T, Yi HM, Yi H, et al
    S897 phosphorylation of EphA2 is indispensable for EphA2-dependent nasopharyngeal carcinoma cell invasion, metastasis and stem properties.
    Cancer Lett. 2019;444:162-174.
    PubMed     Abstract available
    
    
    February 2019
83. LI L, Wang Y, Song G, Zhang X, et al
    HOX cluster-embedded antisense long non-coding RNAs in lung cancer.
    Cancer Lett. 2019 Feb 23. pii: S0304-3835(19)30114.
    PubMed     Abstract available
    
    
    
84. RUANO-RAVINA A, Rodriguez-Martinez A, Torres-Duran M, Barros-Dios JM, et al
    Reply: Residential radon and small cell lung cancer. A systematic review.
    Cancer Lett. 2019 Feb 4. pii: S0304-3835(19)30056.
    PubMed    
    
    
    
85. BEVELACQUA JJ, Dobrzynski L, Welsh J, Mortazavi SMJ, et al
    Commentary regarding "Residential radon and small cell lung cancer. A systematic review".
    Cancer Lett. 2019 Feb 4. pii: S0304-3835(19)30050.
    PubMed     Abstract available
    
    
    
86. CAPPELLI HC, Kanugula AK, Adapala RK, Amin V, et al
    Mechanosensitive TRPV4 channels stabilize VE-cadherin junctions to regulate tumor vascular integrity and metastasis.
    Cancer Lett. 2019;442:15-20.
    PubMed     Abstract available
    
    
    January 2019
87. LIU X, Min S, Wu N, Liu H, et al
    miR-193a-3p inhibition of the Slug activator PAK4 suppresses non-small cell lung cancer aggressiveness via the p53/Slug/L1CAM pathway.
    Cancer Lett. 2019;447:56-65.
    PubMed     Abstract available
    
    
    
88. NEGI H, Merugu SB, Mangukiya HB, Li Z, et al
    Anterior Gradient-2 Monoclonal Antibody Inhibits Lung Cancer Growth and Metastasis by Upregulating p53 Pathway and Without Exerting Any Toxicological Effects: A Preclinical Study.
    Cancer Lett. 2019 Jan 24. pii: S0304-3835(19)30045.
    PubMed     Abstract available
    
    
    
89. HUANG H, Wang Y, Li Q, Fei X, et al
    miR-140-3p functions as a tumor suppressor in squamous cell lung cancer by regulating BRD9.
    Cancer Lett. 2019 Jan 17. pii: S0304-3835(19)30019.
    PubMed     Abstract available
    
    
    
90. JUNG PY, Ryu H, Rhee KJ, Hwang S, et al
    Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-beta and TRAIL and suppress the growth of H460 human lung cancer cells.
    Cancer Lett. 2019;440-441:202-210.
    PubMed     Abstract available
    
    
    
91. HAN Y, Guo W, Ren T, Huang Y, et al
    Tumor-associated macrophages promote lung metastasis and induce epithelial-mesenchymal transition in osteosarcoma by activating the COX-2/STAT3 axis.
    Cancer Lett. 2019;440-441:116-125.
    PubMed     Abstract available
    
    
    
92. JI N, Yang Y, Cai CY, Lei ZN, et al
    Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells.
    Cancer Lett. 2019;440-441:82-93.
    PubMed     Abstract available
    
    
    
93. VELLANKI SH, Cruz RGB, Jahns H, Hudson L, et al
    Natural compound Tetrocarcin-A downregulates Junctional Adhesion Molecule-A in conjunction with HER2 and inhibitor of apoptosis proteins and inhibits tumor cell growth.
    Cancer Lett. 2019;440-441:23-34.
    PubMed     Abstract available
    
    
    December 2018
94. PARK JH, Jung KH, Kim SJ, Yoon YC, et al
    HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer.
    Cancer Lett. 2018 Dec 21. pii: S0304-3835(18)30721.
    PubMed     Abstract available
    
    
    
95. WU Z, Fournel L, Stadler N, Liu J, et al
    Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by Neurotensin antibody.
    Cancer Lett. 2018 Dec 21. pii: S0304-3835(18)30722.
    PubMed     Abstract available
    
    
    November 2018
96. LUKIC A, Wahlund CJE, Gomez C, Brodin D, et al
    Exosomes and cells from lung cancer pleura exudates transform LTC4 to LTD4, promoting cell migration and survival via CysLT1.
    Cancer Lett. 2018 Nov 30. pii: S0304-3835(18)30699.
    PubMed     Abstract available
    
    
    
97. GU J, Mao W, Ren W, Xu F, et al
    Ubiquitin-protein Ligase E3C Maintains Non-small-cell Lung Cancer Stemness by Targeting AHNAK-p53 Complex.
    Cancer Lett. 2018 Nov 29. pii: S0304-3835(18)30695.
    PubMed     Abstract available
    
    
    
98. TREMBLE LF, O'Brien MA, Forde PF
    Electrochemotherapy with cisplatin increases survival and induces immunogenic responses in murine models of lung cancer and colorectal cancer.
    Cancer Lett. 2018 Nov 22. pii: S0304-3835(18)30680.
    PubMed     Abstract available
    
    
    
99. HUANG WT, Chong IW, Chen HL, Li CY, et al
    Pigment epithelium-derived factor inhibits lung cancer migration and invasion by upregulating exosomal thrombospondin 1.
    Cancer Lett. 2018 Nov 12. pii: S0304-3835(18)30646.
    PubMed     Abstract available
    
    
    
100. YU L, Wang L, Mao C, Duraki D, et al
     Estrogen-Independent Myc Overexpression Confers Endocrine Therapy Resistance on Breast Cancer Cells Expressing ERalphaY537S and ERalphaD538G Mutations.
     Cancer Lett. 2018 Nov 9. pii: S0304-3835(18)30662.
     PubMed     Abstract available
     
     
     October 2018
101. ZHANG P, Kang B, Xie G, Li S, et al
     Genomic sequencing and editing revealed the GRM8 signaling pathway as potential therapeutic targets of squamous cell lung cancer.
     Cancer Lett. 2018;442:53-67.
     PubMed     Abstract available
     
     
     
102. GUPTA P, Gupta N, Fofaria NM, Ranjan A, et al
     HER2-mediated GLI2 stabilization promotes anoikis resistance and metastasis of breast cancer cells.
     Cancer Lett. 2018;442:68-81.
     PubMed     Abstract available
     
     
     
103. WANG Z, Fu S, Zhao J, Zhao W, et al
     Transbronchoscopic patient biopsy-derived xenografts as a preclinical model to explore chemorefractory-associated pathways and biomarkers for small-cell lung cancer.
     Cancer Lett. 2018 Oct 19. pii: S0304-3835(18)30628.
     PubMed     Abstract available
     
     
     September 2018
104. DI W, Yang B, Chen J, Xiong H, et al
     Upregulation of long non-coding RNA RAB1A-2 induces FGF1 expression worsening lung cancer prognosis.
     Cancer Lett. 2018 Sep 11. pii: S0304-3835(18)30571.
     PubMed     Abstract available
     
     
     August 2018
105. WANG Y, Wu L, Yao Y, Lu G, et al
     Polo-like kinase 1 inhibitor BI 6727 induces DNA damage and exerts strong antitumor activity in small cell lung cancer.
     Cancer Lett. 2018;436:1-9.
     PubMed     Abstract available
     
     
     July 2018
106. CHIANG CT, Demetriou AN, Ung N, Choudhury N, et al
     mTORC2 contributes to the metabolic reprogramming in EGFR tyrosine-kinase inhibitor resistant cells in non-small cell lung cancer.
     Cancer Lett. 2018 Jul 20. pii: S0304-3835(18)30483.
     PubMed     Abstract available
     
     
     
107. ZHANG DL, Qu LW, Ma L, Zhou YC, et al
     Genome-wide identification of transcription factors that are critical to non-small cell lung cancer.
     Cancer Lett. 2018 Jul 18. pii: S0304-3835(18)30478.
     PubMed     Abstract available
     
     
     
108. LEE YS, Jung YY, Park MH, Yeo IJ, et al
     Deficiency of parkin suppresses melanoma tumor development and metastasis through inhibition of MFN2 ubiquitination.
     Cancer Lett. 2018;433:156-164.
     PubMed     Abstract available
     
     
     June 2018
109. LU Z, Li Y, Che Y, Huang J, et al
     The TGFbeta-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling.
     Cancer Lett. 2018;432:156-168.
     PubMed     Abstract available
     
     
     May 2018
110. LU T, Li Z, Yang Y, Ji W, et al
     Corrigendum to "The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer" [Canc. Lett. 423 (2018) 36-46].
     Cancer Lett. 2018 May 10. pii: S0304-3835(18)30275.
     PubMed    
     
     
     
111. HSU HY, Lin TY, Hu CH, Shu DTF, et al
     Fucoidan Upregulates TLR4/CHOP-Mediated Caspase-3 and PARP Activation to Enhance Cisplatin-Induced Cytotoxicity in Human Lung Cancer Cells.
     Cancer Lett. 2018 May 7. pii: S0304-3835(18)30325.
     PubMed     Abstract available
     
     
     April 2018
112. GUERARD M, Robin T, Perron P, Hatat AS, et al
     Nuclear translocation of IGF1R by intracellular amphiregulin contributes to the resistance of lung tumour cells to EGFR-TKI.
     Cancer Lett. 2018;420:146-155.
     PubMed     Abstract available
     
     
     
113. DU Q, Yan C, Wu SG, Zhang W, et al
     Development and validation of a novel diagnostic nomogram model based on tumor markers for assessing cancer risk of pulmonary lesions: A multicenter study in Chinese population.
     Cancer Lett. 2018;420:236-241.
     PubMed     Abstract available
     
     
     
114. YU F, Liu JB, Wu ZJ, Xie WT, et al
     Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14.
     Cancer Lett. 2018 Apr 24. pii: S0304-3835(18)30289.
     PubMed     Abstract available
     
     
     
115. ZHAO X, Wu X, Qian M, Song Y, et al
     Knockdown of TGF-beta1 expression in human umbilical cord mesenchymal stem cells reverts their exosome-mediated EMT promoting effect on lung cancer cells.
     Cancer Lett. 2018 Apr 24. pii: S0304-3835(18)30293.
     PubMed     Abstract available
     
     
     
116. TAN W, Liao Y, Qiu Y, Liu H, et al
     miRNA 146a promotes chemotherapy resistance in lung cancer cells by targeting DNA damage inducible transcript 3 (CHOP).
     Cancer Lett. 2018 Apr 24. pii: S0304-3835(18)30295.
     PubMed     Abstract available
     
     
     
117. JING P, Zhao N, Ye M, Zhang Y, et al
     Protein arginine methyltransferase 5 promotes lung cancer metastasis via the epigenetic regulation of miR-99 family/FGFR3 signaling.
     Cancer Lett. 2018 Apr 18. pii: S0304-3835(18)30286.
     PubMed     Abstract available
     
     
     
118. YU X, Zhang Y, Ma X, Pertsemlidis A, et al
     miR-195 Potentiates the Efficacy of Microtubule-Targeting Agents in Non-Small Cell Lung Cancer.
     Cancer Lett. 2018 Apr 13. pii: S0304-3835(18)30268.
     PubMed     Abstract available
     
     
     
119. RODRIGUEZ-MARTINEZ A, Torres-Duran M, Barros-Dios JM, Ruano-Ravina A, et al
     Residential radon and small cell lung cancer. A systematic review.
     Cancer Lett. 2018 Apr 11. pii: S0304-3835(18)30264.
     PubMed     Abstract available
     
     
     
120. HU W, Bi ZY, Chen ZL, Liu C, et al
     Emerging landscape of circular RNAs in lung cancer.
     Cancer Lett. 2018 Apr 10. pii: S0304-3835(18)30267.
     PubMed     Abstract available
     
     
     
121. YAN C, Luo L, Urata Y, Goto S, et al
     Nicaraven reduces cancer metastasis to irradiated lungs by decreasing CCL8 and macrophage recruitment.
     Cancer Lett. 2018;418:204-210.
     PubMed     Abstract available
     
     
     March 2018
122. LI D, Wang H, Ding Y, Zhang Z, et al
     Targeting the NRF-2/RHOA/ROCK signaling pathway with a novel aziridonin, YD0514, to suppress breast cancer progression and lung metastasis.
     Cancer Lett. 2018;424:97-108.
     PubMed     Abstract available
     
     
     
123. LE HT, Nguyen HT, Min HY, Hyun SY, et al
     Corrigendum to "Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells" [Canc. Lett. 412 (2018) 297-307].
     Cancer Lett. 2018 Mar 21. pii: S0304-3835(18)30220.
     PubMed    
     
     
     
124. CAO X, Zhou Y, Sun H, Xu M, et al
     EGFR-TKI-induced HSP70 degradation and BER suppression facilitate the occurrence of the EGFR T790M resistant mutation in lung cancer cells.
     Cancer Lett. 2018 Mar 7. pii: S0304-3835(18)30193.
     PubMed     Abstract available
     
     
     
125. ZHANG GN, Zhang YK, Wang YJ, Gupta P, et al
     Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In vitro and in vivo.
     Cancer Lett. 2018 Mar 5. pii: S0304-3835(18)30181.
     PubMed     Abstract available
     
     
     February 2018
126. YANG YF, Lee YC, Lo S, Chung YN, et al
     A positive feedback loop of IL-17B-IL-17RB activates ERK/beta-catenin to promote lung cancer metastasis.
     Cancer Lett. 2018;422:44-55.
     PubMed     Abstract available
     
     
     
127. GOU W, Zhou X, Liu Z, Wang L, et al
     CD74-ROS1 G2032R mutation transcriptionally up-regulates Twist1 in non-small cell lung cancer cells leading to increased migration, invasion, and resistance to crizotinib.
     Cancer Lett. 2018 Feb 22. pii: S0304-3835(18)30171.
     PubMed     Abstract available
     
     
     
128. LU T, Li Z, Yang Y, Ji W, et al
     The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer.
     Cancer Lett. 2018 Feb 13. pii: S0304-3835(18)30142.
     PubMed     Abstract available
     
     
     
129. SAIJO A, Goto H, Nakano M, Mitsuhashi A, et al
     Bone marrow-derived fibrocytes promote stem cell-like properties of lung cancer cells.
     Cancer Lett. 2018 Feb 12. pii: S0304-3835(18)30143.
     PubMed     Abstract available
     
     
     
130. TANG ZH, Lu JJ
     Osimertinib resistance in non-small cell lung cancer: Mechanisms and therapeutic strategies.
     Cancer Lett. 2018 Feb 6. pii: S0304-3835(18)30129.
     PubMed     Abstract available
     
     
     
131. ZHANG Y, Lin Q, Xu T, Deng W, et al
     Out of the darkness and into the light: New strategies for improving treatments for locally advanced non-small cell lung cancer.
     Cancer Lett. 2018 Feb 6. pii: S0304-3835(18)30128.
     PubMed     Abstract available
     
     
     
132. CHAI S, Qian Y, Tang J, Liang Z, et al
     Retraction notice to "Ca2+/Calmodulin-dependent protein kinase IIgamma, a critical mediator of the NF-kappaB network, is a novel therapeutic target in non-small cell lung cancer" [Cancer Lett. 344(1) (2014) 119-128].
     Cancer Lett. 2018;414:312.
     PubMed    
     
     
     
133. GRUNDEMANN C, Huber R
     Chemoprevention with isothiocyanates - From bench to bedside.
     Cancer Lett. 2018;414:26-33.
     PubMed     Abstract available
     
     
     January 2018
134. LI K, Sun D, Gou Q, Ke X, et al
     Long non-coding RNA linc00460 promotes epithelial-mesenchymal transition and cell migration in lung cancer cells.
     Cancer Lett. 2018 Jan 30. pii: S0304-3835(18)30093.
     PubMed     Abstract available
     
     
     
135. ZHANG Y, Zhang X, Ye M, Jing P, et al
     FBW7 loss promotes epithelial-to-mesenchymal transition in non-small cell lung cancer through the stabilization of Snail protein.
     Cancer Lett. 2018 Jan 17. pii: S0304-3835(18)30069.
     PubMed     Abstract available
     
     
     
136. LI C, Wan L, Liu Z, Xu G, et al
     Long non-coding RNA XIST promotes TGF-beta-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
     Cancer Lett. 2018 Jan 12. pii: S0304-3835(18)30058.
     PubMed     Abstract available
     
     
     
137. WU D, Zhao B, Qi X, Peng F, et al
     Nogo-B receptor promotes epithelial-mesenchymal transition in non-small cell lung cancer cells through the Ras/ERK/Snail1 pathway.
     Cancer Lett. 2018 Jan 10. pii: S0304-3835(18)30052.
     PubMed     Abstract available
     
     
     
138. WANG L, Syn NL, Subhash VV, Any Y, et al
     Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling.
     Cancer Lett. 2018 Jan 3. pii: S0304-3835(18)30003.
     PubMed     Abstract available
     
     
     
139. FU XT, Shi YH, Zhou J, Peng YF, et al
     MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma.
     Cancer Lett. 2018;412:108-117.
     PubMed     Abstract available
     
     
     December 2017
140. LEE JY, Talhi O, Jang D, Cerella C, et al
     Cytostatic hydroxycoumarin OT52 induces ER/Golgi stress and STAT3 inhibition triggering non-canonical cell death and synergy with BH3 mimetics in lung cancer.
     Cancer Lett. 2017;416:94-108.
     PubMed     Abstract available
     
     
     
141. MAO Q, Jiang F, Yin R, Wang J, et al
     Interplay between the lung microbiome and lung cancer.
     Cancer Lett. 2017;415:40-48.
     PubMed     Abstract available
     
     
     
142. TESSEMA M, Yingling CM, Picchi MA, Wu G, et al
     ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status.
     Cancer Lett. 2017;410:191-200.
     PubMed     Abstract available
     
     
     
143. YOSHIKAWA Y, Takano O, Kato I, Takahashi Y, et al
     Ras inhibitors display an anti-metastatic effect by downregulation of lysyl oxidase through inhibition of the Ras-PI3K-Akt-HIF-1alpha pathway.
     Cancer Lett. 2017;410:82-91.
     PubMed     Abstract available
     
     
     November 2017
144. WANG J, Tian L, Khan MN, Zhang L, et al
     Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-kappaB mediated epithelial-mesenchymal transition and stemness.
     Cancer Lett. 2017 Nov 30. pii: S0304-3835(17)30762.
     PubMed     Abstract available
     
     
     
145. XUE X, Fei X, Hou W, Zhang Y, et al
     miR-342-3p suppresses cell proliferation and migration by targeting AGR2 in non-small cell lung cancer.
     Cancer Lett. 2017;412:170-178.
     PubMed     Abstract available
     
     
     
146. JING L, Song F, Liu Z, Li J, et al
     MLKL-PITPalpha signaling-mediated necroptosis contributes to cisplatin-triggered cell death in lung cancer A549 cells.
     Cancer Lett. 2017 Nov 2. pii: S0304-3835(17)30693.
     PubMed     Abstract available
     
     
     October 2017
147. LIU X, Chen B, You W, Xue S, et al
     The membrane bile acid receptor TGR5 drives cell growth and migration via activation of the JAK2/STAT3 signaling pathway in non-small cell lung cancer.
     Cancer Lett. 2017 Oct 23. pii: S0304-3835(17)30652.
     PubMed     Abstract available
     
     
     
148. LE HT, Nguyen HT, Min HY, Hyun SY, et al
     Panaxynol, a natural Hsp90 inhibitor, effectively targets both lung cancer stem and non-stem cells.
     Cancer Lett. 2017 Oct 20. pii: S0304-3835(17)30648.
     PubMed     Abstract available
     
     
     
149. LI X, Ma T, Zhang Q, Chen YG, et al
     Modified-FOLFIRINOX in metastatic pancreatic cancer: A prospective study in Chinese population.
     Cancer Lett. 2017;406:22-26.
     PubMed     Abstract available
     
     
     
150. TANG ZH, Cao WX, Guo X, Dai XY, et al
     Identification of a novel autophagic inhibitor cepharanthine to enhance the anti-cancer property of dacomitinib in non-small cell lung cancer.
     Cancer Lett. 2017 Oct 9. pii: S0304-3835(17)30624.
     PubMed     Abstract available
     
     
     
151. TORRES-DURAN M, Ruano-Ravina A, Kelsey KT, Parente-Lamelas I, et al
     Environmental tobacco smoke exposure and EGFR and ALK alterations in never smokers' lung cancer. Results from the LCRINS study.
     Cancer Lett. 2017 Oct 5. pii: S0304-3835(17)30603.
     PubMed     Abstract available
     
     
     
152. YANG H, Lee MH, Park I, Jeon H, et al
     HSP90 inhibitor (NVP-AUY922) enhances the anti-cancer effect of BCL-2 inhibitor (ABT-737) in small cell lung cancer expressing BCL-2.
     Cancer Lett. 2017;411:19-26.
     PubMed     Abstract available
     
     
     
153. BETTI M, Casalone E, Ferrante D, Aspesi A, et al
     Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma.
     Cancer Lett. 2017;405:38-45.
     PubMed     Abstract available
     
     
     September 2017
154. HUANG GX, Wang Y, Su J, Zhou P, et al
     Up-regulation of Rho-associated kinase 1/2 by glucocorticoids promotes migration, invasion and metastasis of melanoma.
     Cancer Lett. 2017 Sep 15. pii: S0304-3835(17)30552.
     PubMed     Abstract available
     
     
     
155. KIM SJ, Jung KH, Son MK, Park JH, et al
     Tumor vessel normalization by the PI3K inhibitor HS-173 enhances drug delivery.
     Cancer Lett. 2017;403:339-353.
     PubMed     Abstract available
     
     
     
156. CHAN KK, Leung CO, Wong CC, Ho DW, et al
     Secretory Stanniocalcin 1 promotes metastasis of hepatocellular carcinoma through activation of JNK signaling pathway.
     Cancer Lett. 2017;403:330-338.
     PubMed     Abstract available
     
     
     
157. CAO L, Qi L, Zhang L, Song W, et al
     Human nonsense-mediated RNA decay regulates EMT by targeting the TGF-ss signaling pathway in lung adenocarcinoma.
     Cancer Lett. 2017;403:246-259.
     PubMed     Abstract available
     
     
     
158. LIU CH, Lan CT, Chou JF, Tseng TJ, et al
     CHSY1 promotes aggressive phenotypes of hepatocellular carcinoma cells via activation of the hedgehog signaling pathway.
     Cancer Lett. 2017;403:280-288.
     PubMed     Abstract available
     
     
     
159. LIANG Z, Cheng Y, Chen Y, Hu Y, et al
     EGFR T790M ctDNA testing platforms and their role as companion diagnostics: Correlation with clinical outcomes to EGFR-TKIs.
     Cancer Lett. 2017;403:186-194.
     PubMed     Abstract available
     
     
     
160. WANG C, Zhou X, Li W, Li M, et al
     Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
     Cancer Lett. 2017;403:271-279.
     PubMed     Abstract available
     
     
     
161. ZHOU J, Zhang S, Chen X, Zheng X, et al
     Palbociclib, a selective CDK4/6 inhibitor, enhances the effect of selumetinib in RAS-driven non-small cell lung cancer.
     Cancer Lett. 2017 Sep 1. pii: S0304-3835(17)30518.
     PubMed     Abstract available
     
     
     August 2017
162. BAI Z, Gao M, Zhang H, Guan Q, et al
     BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
     Cancer Lett. 2017;402:81-92.
     PubMed     Abstract available
     
     
     
163. WANG ZQ, He CY, Hu L, Shi HP, et al
     Long noncoding RNA UCA1 promotes tumour metastasis by inducing GRK2 degradation in gastric cancer.
     Cancer Lett. 2017 Aug 23. pii: S0304-3835(17)30490.
     PubMed     Abstract available
     
     
     
164. ZHOU L, Lv T, Zhang Q, Zhu Q, et al
     The biology, function and clinical implications of exosomes in lung cancer.
     Cancer Lett. 2017 Aug 12. pii: S0304-3835(17)30480.
     PubMed     Abstract available
     
     
     
165. PARK KS, Yang H, Choi J, Seo S, et al
     The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancer.
     Cancer Lett. 2017 Aug 7. pii: S0304-3835(17)30464.
     PubMed     Abstract available
     
     
     
166. PISANU ME, Noto A, De Vitis C, Morrone S, et al
     Blockade of Stearoyl-CoA-Desaturase 1 activity reverts resistance to Cisplatin in lung cancer stem cells.
     Cancer Lett. 2017 Aug 7. pii: S0304-3835(17)30463.
     PubMed     Abstract available
     
     
     
167. LI J, Tian H, Pan J, Jiang N, et al
     Pecanex functions as a competitive endogenous RNA of S-phase kinase associated protein 2 in lung cancer.
     Cancer Lett. 2017 Aug 5. pii: S0304-3835(17)30466.
     PubMed     Abstract available
     
     
     
168. YANG D, Cao X, Wang F, Jiang H, et al
     LFG-500, a novel synthetic flavonoid, suppresses epithelial-mesenchymal transition in human lung adenocarcinoma cells by inhibiting NLRP3 in inflammatory microenvironment.
     Cancer Lett. 2017;400:137-148.
     PubMed     Abstract available
     
     
     
169. WU J, He Z, Yang XM, Li KL, et al
     RCCD1 depletion attenuates TGF-beta-induced EMT and cell migration by stabilizing cytoskeletal microtubules in NSCLC cells.
     Cancer Lett. 2017;400:18-29.
     PubMed     Abstract available
     
     
     July 2017
170. TONG CWS, Wu WKK, Loong HHF, Cho WCS, et al
     Drug combination approach to overcome resistance to EGFR tyrosine kinase inhibitors in lung cancer.
     Cancer Lett. 2017 Jul 31. pii: S0304-3835(17)30459.
     PubMed     Abstract available
     
     
     
171. STAPELFELD C, Neumann KT, Maser E
     Different inhibitory potential of sex hormones on NNK detoxification in vitro: a possible explanation for gender-specific lung cancer risk.
     Cancer Lett. 2017 Jul 22. pii: S0304-3835(17)30451.
     PubMed     Abstract available
     
     
     
172. MENG X, Liu Y, Zhang J, Teng F, et al
     PD-1/PD-L1 checkpoint blockades in non-small cell lung cancer: New development and challenges.
     Cancer Lett. 2017 Jul 6. pii: S0304-3835(17)30415.
     PubMed     Abstract available
     
     
     
173. GORZALCZANY Y, Akiva E, Klein O, Merimsky O, et al
     Mast cells are directly activated by contact with cancer cells by a mechanism involving autocrine formation of adenosine and autocrine/paracrine signaling of the adenosine A3 receptor.
     Cancer Lett. 2017;397:23-32.
     PubMed     Abstract available
     
     
     June 2017
174. BROCK M, Mei Y
     Protein functional effector sncRNAs (pfeRNAs) in lung cancer.
     Cancer Lett. 2017 Jun 19. pii: S0304-3835(17)30394.
     PubMed     Abstract available
     
     
     
175. DENG M, Zeng C, Lu X, He X, et al
     miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
     Cancer Lett. 2017 Jun 17. pii: S0304-3835(17)30387.
     PubMed     Abstract available
     
     
     
176. CHANG TH, Tsai MF, Gow CH, Wu SG, et al
     Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
     Cancer Lett. 2017;402:190-202.
     PubMed     Abstract available
     
     
     
177. CHANG YC, Chan YC, Chang WM, Lin YF, et al
     Feedback regulation of ALDOA activates the HIF-1alpha/MMP9 axis to promote lung cancer progression.
     Cancer Lett. 2017;403:28-36.
     PubMed     Abstract available
     
     
     
178. KWON OS, Hong SK, Kwon SJ, Go YH, et al
     BCL2 induced by LAMTOR3/MAPK is a druggable target of chemoradioresistance in mesenchymal lung cancer.
     Cancer Lett. 2017 Jun 10. pii: S0304-3835(17)30355.
     PubMed     Abstract available
     
     
     
179. DONG X, Liao W, Zhang L, Tu X, et al
     RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
     Cancer Lett. 2017 Jun 6. pii: S0304-3835(17)30370.
     PubMed     Abstract available
     
     
     
180. NERI S, Miyashita T, Hashimoto H, Suda Y, et al
     Fibroblast-led cancer cell invasion is activated by epithelial-mesenchymal transition through platelet-derived growth factor BB secretion of lung adenocarcinoma.
     Cancer Lett. 2017;395:20-30.
     PubMed     Abstract available
     
     
     May 2017
181. SILVA PM, Ribeiro N, Lima RT, Andrade C, et al
     Suppression of spindly delays mitotic exit and exacerbates cell death response of cancer cells treated with low doses of paclitaxel.
     Cancer Lett. 2017;394:33-42.
     PubMed     Abstract available
     
     
     
182. CHEN S, Dong Z, Yang P, Wang X, et al
     Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis.
     Cancer Lett. 2017;394:22-32.
     PubMed     Abstract available
     
     
     
183. CASTANON E, Soltermann A, Lopez I, Roman M, et al
     The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche.
     Cancer Lett. 2017 May 24. pii: S0304-3835(17)30342.
     PubMed     Abstract available
     
     
     
184. ZHANG J, Kong L, Jiao Q, Li M, et al
     Stereotactic ablative radiotherapy in treatment of early-stage non-small cell lung cancer: Unsolved questions and frontiers ahead.
     Cancer Lett. 2017 May 16. pii: S0304-3835(17)30311.
     PubMed     Abstract available
     
     
     April 2017
185. WANG Y, Zhou Y, Tao F, Chai S, et al
     N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc.
     Cancer Lett. 2017 Apr 26. pii: S0304-3835(17)30292.
     PubMed     Abstract available
     
     
     February 2017
186. SHEN CJ, Chan SH, Lee CT, Huang WC, et al
     Oleic acid-induced ANGPTL4 enhances head and neck squamous cell carcinoma anoikis resistance and metastasis via up-regulation of fibronectin.
     Cancer Lett. 2017;386:110-122.
     PubMed     Abstract available
     
     
     November 2016
187. KIM JY, Lee N, Kim YJ, Cho Y, et al
     Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation.
     Cancer Lett. 2016 Nov 25. pii: S0304-3835(16)30710.
     PubMed     Abstract available
     
     
     
188. ZYSK A, DeNichilo MO, Panagopoulos V, Zinonos I, et al
     Adoptive transfer of ex vivo expanded Vgamma9Vdelta2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer.
     Cancer Lett. 2016 Nov 16. pii: S0304-3835(16)30699.
     PubMed     Abstract available
     
     
     July 2016
189. KONG J, Sun W, Li C, Wan L, et al
     Long non-coding RNA LINC01133 inhibits epithelial-mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6.
     Cancer Lett. 2016;380:476-484.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: